[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Impact of Diabetes and Inpatient Outcomes in Community-Acquired Pneumonia: Insights from the National Inpatient Sample",
    "section": "",
    "text": "Reference Papers:\n\nShah et al. 2021"
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Impact of Diabetes and Inpatient Outcomes in Community-Acquired Pneumonia: Insights from the National Inpatient Sample",
    "section": "",
    "text": "Reference Papers:\n\nShah et al. 2021"
  },
  {
    "objectID": "quarto/index.html#preamble-1",
    "href": "quarto/index.html#preamble-1",
    "title": "Impact of Diabetes and Inpatient Outcomes in Community-Acquired Pneumonia: Insights from the National Inpatient Sample",
    "section": "Preamble:",
    "text": "Preamble:\n\nStudy Objective: To examine the impact of diabetes on outcomes among admissions with pneumonia.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020. The NIS is part of the Healthcare Cost and Utilization Project (HCUP) and provides a stratified sample of inpatient discharges from U.S. community hospitals across all payers.\nCohort Definition: Patients were included if they met the following criteria\n\nAge ≥18 years\nHad a diagnosis of pneumonia\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSecondary Outcomes:\n\nPatient requiring mechanical ventilation\nSepsis\n\nCovariates for Adjustment: All models adjusted for the following\n\nDemographics: Age, sex, race, income, insurance, location of patient’s residence, hospital region, hospital bedsize, hospital location, and teaching status.\nMedical History: Hypertension, cardiac arrhythmias, hyperlipidemia, coronary artery disease, peripheral vascular disease, pulmonary circulation disorders, heart failure, chronic kidney disease, chronic pulmonary disease, dementia, obstructive sleep apnea, anemia, liver disease, alcohol abuse, drug abuse, obesity, electrolyte and fluid imbalance.\n\nStatistical Methods:\n\nUnivariable Analysis:\n\nCategorical variables: Compared using Pearson’s chi-square test with Rao & Scott adjustment\nContinuous variables: Analyzed using the design-based Kruskal–Wallis test, a non-parametric alternative suitable for survey-weighted data\n\nMultivariable Analysis:\n\nBinary outcomes (e.g., mortality): Survey-weighted logistic regression using the quasibinomial family\nContinuous outcomes (e.g., LOS, hospital charges): Survey-weighted linear regression using the gaussian family\nResults reported as adjusted odds ratios (aORs) or beta coefficients with 95% confidence intervals\n\n\nSoftware: All statistical analyses were performed using the R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria), incorporating survey-weighted procedures via the survey package to account for the complex sampling design of NIS."
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Impact of Diabetes and Inpatient Outcomes in Community-Acquired Pneumonia: Insights from the National Inpatient Sample",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 22,5201\nNo\nN = 14,2551\nYes\nN = 8,2651\np-value2\n\n\n\n\nAge, y\n68 (16)\n66 (17)\n71 (14)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n&lt;0.001\n\n\n    Female\n11,315 (50%)\n6,800 (48%)\n4,515 (55%)\n\n\n\n\n    Male\n11,205 (50%)\n7,455 (52%)\n3,750 (45%)\n\n\n\n\nRace\n\n\n\n\n\n\n0.2\n\n\n    White\n14,815 (68%)\n9,460 (68%)\n5,355 (67%)\n\n\n\n\n    Asian or Pacific Islander\n875 (4.0%)\n540 (3.9%)\n335 (4.2%)\n\n\n\n\n    Black\n3,005 (14%)\n1,950 (14%)\n1,055 (13%)\n\n\n\n\n    Hispanic\n2,325 (11%)\n1,365 (9.9%)\n960 (12%)\n\n\n\n\n    Native American\n150 (0.7%)\n80 (0.6%)\n70 (0.9%)\n\n\n\n\n    Other\n665 (3.0%)\n455 (3.3%)\n210 (2.6%)\n\n\n\n\nResidential income\n\n\n\n\n\n\n0.8\n\n\n    $1 - $51,999\n6,885 (31%)\n4,390 (32%)\n2,495 (31%)\n\n\n\n\n    $52,000 - $65,999\n5,820 (26%)\n3,695 (27%)\n2,125 (26%)\n\n\n\n\n    $66,000 - $87,999\n5,250 (24%)\n3,280 (24%)\n1,970 (24%)\n\n\n\n\n    $88,000 or more\n4,060 (18%)\n2,505 (18%)\n1,555 (19%)\n\n\n\n\nExpected primary payer\n\n\n\n\n\n\n&lt;0.001\n\n\n    Private\n4,090 (18%)\n2,955 (21%)\n1,135 (14%)\n\n\n\n\n    Medicaid\n2,895 (13%)\n2,155 (15%)\n740 (9.0%)\n\n\n\n\n    Medicare\n14,970 (67%)\n8,730 (61%)\n6,240 (76%)\n\n\n\n\n    Other\n550 (2.4%)\n405 (2.8%)\n145 (1.8%)\n\n\n\n\nHospital region\n\n\n\n\n\n\n0.3\n\n\n    Midwest\n6,230 (28%)\n3,915 (27%)\n2,315 (28%)\n\n\n\n\n    Northeast\n3,370 (15%)\n2,250 (16%)\n1,120 (14%)\n\n\n\n\n    South\n6,975 (31%)\n4,340 (30%)\n2,635 (32%)\n\n\n\n\n    West\n5,945 (26%)\n3,750 (26%)\n2,195 (27%)\n\n\n\n\nHypertension\n15,695 (70%)\n8,835 (62%)\n6,860 (83%)\n&lt;0.001\n\n\nHyperlipidemia\n9,075 (40%)\n4,660 (33%)\n4,415 (53%)\n&lt;0.001\n\n\nCoronary artery disease\n5,570 (25%)\n2,840 (20%)\n2,730 (33%)\n&lt;0.001\n\n\nPeripheral vascular disease\n2,060 (9.1%)\n1,325 (9.3%)\n735 (8.9%)\n0.6\n\n\nCardiac arrhythmias\n7,575 (34%)\n4,455 (31%)\n3,120 (38%)\n&lt;0.001\n\n\nPulmonary circulation disorders\n3,670 (16%)\n1,900 (13%)\n1,770 (21%)\n&lt;0.001\n\n\nHeart failure\n8,145 (36%)\n4,230 (30%)\n3,915 (47%)\n&lt;0.001\n\n\nChronic kidney disease\n6,360 (28%)\n2,470 (17%)\n3,890 (47%)\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n10,070 (45%)\n6,570 (46%)\n3,500 (42%)\n0.014\n\n\nDementia\n2,405 (11%)\n1,355 (9.5%)\n1,050 (13%)\n&lt;0.001\n\n\nLiver disease\n1,555 (6.9%)\n975 (6.8%)\n580 (7.0%)\n0.8\n\n\nObstructive sleep apnea\n2,155 (9.6%)\n1,035 (7.3%)\n1,120 (14%)\n&lt;0.001\n\n\nAnemia\n1,710 (7.6%)\n1,035 (7.3%)\n675 (8.2%)\n0.3\n\n\nAlcohol use disorder\n4,470 (20%)\n2,835 (20%)\n1,635 (20%)\n&gt;0.9\n\n\nObesity\n3,670 (16%)\n1,900 (13%)\n1,770 (21%)\n&lt;0.001\n\n\nElectrolyte and fluid imbalance\n3,670 (16%)\n1,900 (13%)\n1,770 (21%)\n&lt;0.001\n\n\nDrug_abuse\n635 (2.8%)\n400 (2.8%)\n235 (2.8%)\n&gt;0.9\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nNo\nN = 14,2551\nYes\nN = 8,2651\np-value2\n\n\n\n\nDied during hospitalization\n1,205 (8.5%)\n655 (7.9%)\n0.5\n\n\nSepsis\n4,870 (34%)\n3,120 (38%)\n0.018\n\n\nMechanical Ventilation\n\n\n\n\n\n\n\n\n    No\n14,255 (100%)\n8,265 (100%)\n\n\n\n\nLength of stay (days)\n7 (9)\n8 (9)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n93,166 (174,414)\n100,573 (164,724)\n&lt;0.001\n\n\n\n1 n (%); Mean (SD)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; NA; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Impact of Diabetes and Inpatient Outcomes in Community-Acquired Pneumonia: Insights from the National Inpatient Sample",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nDiabetes Categories\n\n\n\n\n\n\n\n\n    Without Diabetes\n—\n—\n\n\n\n\n    Diabetes with complications\n0.80\n0.54, 1.20\n0.3\n\n\n    Diabetes without complications\n1.02\n0.76, 1.36\n0.9\n\n\nAge, y\n1.03\n1.02, 1.04\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.14\n0.92, 1.43\n0.2\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.07\n0.57, 2.02\n0.8\n\n\n    Black\n1.25\n0.87, 1.79\n0.2\n\n\n    Hispanic\n1.68\n1.16, 2.44\n0.006\n\n\n    Native American\n0.90\n0.21, 3.80\n0.9\n\n\n    Other\n1.37\n0.75, 2.51\n0.3\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.20\n0.87, 1.65\n0.3\n\n\n    $66,000 - $87,999\n1.25\n0.90, 1.75\n0.2\n\n\n    $88,000 or more\n1.06\n0.74, 1.53\n0.8\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.82\n0.52, 1.29\n0.4\n\n\n    Medicare\n0.86\n0.59, 1.25\n0.4\n\n\n    Other\n1.09\n0.49, 2.42\n0.8\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.77\n1.23, 2.55\n0.002\n\n\n    South\n1.22\n0.88, 1.70\n0.2\n\n\n    West\n1.23\n0.85, 1.78\n0.3\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.59\n0.45, 0.78\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.65\n0.50, 0.84\n0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.85\n0.63, 1.16\n0.3\n\n\nCardiac arrhythmias\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.64\n1.26, 2.14\n&lt;0.001\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.19\n0.84, 1.69\n0.3\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.27\n0.85, 1.91\n0.2\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.99\n0.77, 1.29\n&gt;0.9\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.30\n1.00, 1.68\n0.046\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.68\n0.53, 0.86\n0.002\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.85\n0.60, 1.20\n0.4\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3.20\n2.26, 4.54\n&lt;0.001\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.67\n0.41, 1.09\n0.11\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.78\n0.49, 1.24\n0.3\n\n\nAlcohol use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.40\n1.05, 1.87\n0.022\n\n\nDrug_abuse\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.41\n0.11, 1.45\n0.2\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nMechanical Ventilation:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nDiabetes Categories\n\n\n\n\n\n\n\n\n    Without Diabetes\n—\n—\n\n\n\n\n    Diabetes with complications\n1.00\n0.91, 1.10\n&gt;0.9\n\n\n    Diabetes without complications\n1.00\n0.93, 1.08\n&gt;0.9\n\n\nAge, y\n1.00\n1.00, 1.00\n&gt;0.9\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.00\n0.94, 1.06\n&gt;0.9\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.00\n0.83, 1.21\n&gt;0.9\n\n\n    Black\n1.00\n0.88, 1.14\n&gt;0.9\n\n\n    Hispanic\n1.00\n0.85, 1.18\n&gt;0.9\n\n\n    Native American\n1.00\n0.60, 1.66\n&gt;0.9\n\n\n    Other\n1.00\n0.78, 1.28\n&gt;0.9\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.00\n0.88, 1.13\n&gt;0.9\n\n\n    $66,000 - $87,999\n1.00\n0.86, 1.16\n&gt;0.9\n\n\n    $88,000 or more\n1.00\n0.83, 1.20\n&gt;0.9\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.00\n0.88, 1.14\n&gt;0.9\n\n\n    Medicare\n1.00\n0.91, 1.10\n&gt;0.9\n\n\n    Other\n1.00\n0.79, 1.27\n&gt;0.9\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.00\n0.77, 1.30\n&gt;0.9\n\n\n    South\n1.00\n0.81, 1.24\n&gt;0.9\n\n\n    West\n1.00\n0.81, 1.23\n&gt;0.9\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.92, 1.08\n&gt;0.9\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.93, 1.08\n&gt;0.9\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.92, 1.09\n&gt;0.9\n\n\nCardiac arrhythmias\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.93, 1.07\n&gt;0.9\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.91, 1.10\n&gt;0.9\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.88, 1.13\n&gt;0.9\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.93, 1.08\n&gt;0.9\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.93, 1.08\n&gt;0.9\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.94, 1.07\n&gt;0.9\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.90, 1.11\n&gt;0.9\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.88, 1.14\n&gt;0.9\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.89, 1.12\n&gt;0.9\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.89, 1.12\n&gt;0.9\n\n\nAlcohol use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.87, 1.14\n&gt;0.9\n\n\nDrug_abuse\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.84, 1.20\n&gt;0.9\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nSepsis:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nDiabetes Categories\n\n\n\n\n\n\n\n\n    Without Diabetes\n—\n—\n\n\n\n\n    Diabetes with complications\n1.06\n0.86, 1.31\n0.6\n\n\n    Diabetes without complications\n1.28\n1.08, 1.52\n0.004\n\n\nAge, y\n1.00\n0.99, 1.00\n0.12\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.28\n1.12, 1.46\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.40\n1.01, 1.95\n0.045\n\n\n    Black\n1.05\n0.85, 1.29\n0.6\n\n\n    Hispanic\n0.90\n0.71, 1.12\n0.3\n\n\n    Native American\n0.94\n0.46, 1.93\n0.9\n\n\n    Other\n1.17\n0.77, 1.78\n0.5\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.05\n0.89, 1.25\n0.6\n\n\n    $66,000 - $87,999\n1.08\n0.89, 1.30\n0.4\n\n\n    $88,000 or more\n1.30\n1.04, 1.62\n0.019\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.92\n0.73, 1.15\n0.5\n\n\n    Medicare\n1.31\n1.08, 1.59\n0.007\n\n\n    Other\n0.93\n0.59, 1.47\n0.8\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.90\n0.70, 1.14\n0.4\n\n\n    South\n0.98\n0.80, 1.20\n0.9\n\n\n    West\n1.20\n0.95, 1.50\n0.12\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.75\n0.64, 0.88\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.10\n0.95, 1.28\n0.2\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.75\n0.63, 0.89\n&lt;0.001\n\n\nCardiac arrhythmias\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.91\n0.79, 1.06\n0.2\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.13\n0.93, 1.36\n0.2\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.01\n0.80, 1.27\n&gt;0.9\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.11\n0.95, 1.30\n0.2\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.02\n0.87, 1.19\n0.8\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.78\n0.68, 0.89\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.32\n1.06, 1.63\n0.012\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.79\n1.39, 2.30\n&lt;0.001\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.83\n0.65, 1.06\n0.14\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.27\n1.01, 1.61\n0.043\n\n\nAlcohol use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.88\n0.74, 1.05\n0.2\n\n\nDrug_abuse\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.91\n0.60, 1.37\n0.6\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Impact of Diabetes and Inpatient Outcomes in Community-Acquired Pneumonia: Insights from the National Inpatient Sample",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nDiabetes Categories\n\n\n\n\n\n\n\n\n    Without Diabetes\n—\n—\n\n\n\n\n    Diabetes with complications\n-0.49\n-1.0, 0.06\n0.083\n\n\n    Diabetes without complications\n1.2\n0.47, 2.0\n0.002\n\n\nAge, y\n-0.03\n-0.05, 0.00\n0.015\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.27\n-0.26, 0.81\n0.3\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.9\n-0.16, 3.9\n0.071\n\n\n    Black\n0.34\n-0.47, 1.1\n0.4\n\n\n    Hispanic\n1.2\n-0.23, 2.5\n0.10\n\n\n    Native American\n-0.11\n-2.5, 2.3\n&gt;0.9\n\n\n    Other\n0.49\n-0.82, 1.8\n0.5\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-0.53\n-1.2, 0.13\n0.12\n\n\n    $66,000 - $87,999\n0.41\n-0.43, 1.2\n0.3\n\n\n    $88,000 or more\n-0.36\n-1.1, 0.41\n0.4\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n-0.15\n-1.4, 1.1\n0.8\n\n\n    Medicare\n0.02\n-0.88, 0.91\n&gt;0.9\n\n\n    Other\n-0.80\n-2.8, 1.2\n0.4\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.1\n0.06, 2.1\n0.039\n\n\n    South\n0.61\n-0.14, 1.4\n0.11\n\n\n    West\n0.21\n-0.80, 1.2\n0.7\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.25\n-0.95, 0.44\n0.5\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.55\n-1.1, -0.01\n0.046\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.88\n-1.4, -0.37\n&lt;0.001\n\n\nCardiac arrhythmias\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.5\n0.84, 2.1\n&lt;0.001\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.60\n-0.19, 1.4\n0.14\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.02\n-0.76, 0.73\n&gt;0.9\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.2\n0.53, 1.9\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.72\n-0.06, 1.5\n0.071\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.0\n-1.5, -0.47\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.07\n-0.70, 0.85\n0.9\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.7\n0.47, 2.9\n0.007\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.56\n-1.3, 0.24\n0.2\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.2\n0.22, 2.1\n0.016\n\n\nAlcohol use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.01, 1.7\n0.046\n\n\nDrug_abuse\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n5.3\n1.2, 9.5\n0.011\n\n\n\nAbbreviation: CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nDiabetes Categories\n\n\n\n\n\n\n\n\n    Without Diabetes\n—\n—\n\n\n\n\n    Diabetes with complications\n-7,698\n-20,414, 5,019\n0.2\n\n\n    Diabetes without complications\n16,930\n2,781, 31,079\n0.019\n\n\nAge, y\n-769\n-1,259, -279\n0.002\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n9,004\n-1,303, 19,312\n0.087\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n47,972\n11,497, 84,448\n0.010\n\n\n    Black\n7,524\n-7,111, 22,158\n0.3\n\n\n    Hispanic\n34,577\n9,032, 60,121\n0.008\n\n\n    Native American\n-11,002\n-43,453, 21,449\n0.5\n\n\n    Other\n18,738\n-5,629, 43,104\n0.13\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-1,658\n-14,210, 10,894\n0.8\n\n\n    $66,000 - $87,999\n17,628\n2,525, 32,731\n0.022\n\n\n    $88,000 or more\n5,741\n-10,442, 21,923\n0.5\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n-1,534\n-26,328, 23,260\n&gt;0.9\n\n\n    Medicare\n-1,475\n-18,581, 15,631\n0.9\n\n\n    Other\n-7,638\n-38,385, 23,110\n0.6\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n24,516\n7,554, 41,477\n0.005\n\n\n    South\n24,529\n10,422, 38,635\n&lt;0.001\n\n\n    West\n56,991\n36,443, 77,540\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n209\n-13,927, 14,346\n&gt;0.9\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-11,091\n-21,641, -540\n0.039\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-7,467\n-17,199, 2,264\n0.13\n\n\nCardiac arrhythmias\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n24,737\n12,174, 37,299\n&lt;0.001\n\n\nPulmonary circulation disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n12,791\n-1,571, 27,153\n0.081\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1,168\n-13,823, 16,159\n0.9\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n15,448\n3,247, 27,649\n0.013\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n6,582\n-6,979, 20,142\n0.3\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-15,314\n-24,240, -6,387\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-20,208\n-29,620, -10,796\n&lt;0.001\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n43,358\n16,131, 70,585\n0.002\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-7,678\n-26,145, 10,788\n0.4\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n6,456\n-9,679, 22,590\n0.4\n\n\nAlcohol use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n7,954\n-9,047, 24,956\n0.4\n\n\nDrug_abuse\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n57,232\n-15,372, 129,836\n0.12\n\n\n\nAbbreviation: CI = Confidence Interval"
  }
]